A Long-Term, Observational Study within the Corrona Inflammatory Bowel Disease (IBD) Registry to Characterize the Safety of Tofacitinib in Patients with Ulcerative Colitis in the Post-Approval Setting

28/06/2019
14/03/2024
EU PAS number:
EUPAS30314
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Final_Protocol_A3921329_Tofacitinib UC Corrona PASS_6.5.2019_REDACTED

English (928.31 KB - PDF) View document
Updated protocol

FINAL_Protocol_A3921329_Tofacitinib UC Corrona PASS_1.24.2020_REDACTED

First published: 22/02/2024
English (690.08 KB - PDF) View document
Study results
Study report
Other information